T\u00fcrkiye’de de kullan\u0131lan mRNA bazl\u0131 Covid-19 a\u015f\u0131s\u0131n\u0131 \u00fcreten Pfizer ile BioNTech’e \u015fok su\u00e7lama ABD merkezli ila\u00e7 \u015firketi Moderna’dan geldi.<\/b><\/p>\n
D\u00fcnya Omicron varyant\u0131na kar\u015f\u0131 geli\u015ftirilecek yeni Covid-19 a\u015f\u0131lar\u0131n\u0131 beklerken iki T\u00fcrk\u2019\u00fcn Almanya\u2019da kurdu\u011fu BioNTech ve Pfizer\u2019a \u015fok bir su\u00e7lama ABD\u2019den geldi\u2026<\/p>\n
T\u00fcrkiye\u2019de de kullan\u0131lan mRNA bazl\u0131 Covid-19 a\u015f\u0131s\u0131n\u0131 geli\u015ftiren Pfizer\/BioNTech\u2019in rakibi olan Moderna, \u00e7ok sert bir hamle yapt\u0131 ve iki \u015firketi \u201cmRNA teknolojisini kopyalamakla\u201d su\u00e7lad\u0131.<\/p>\n
\u0130ngiltere\u2019nin sayg\u0131n gazetelerinden Financial Times\u2019ta yer alan haberde, Moderna\u2019n\u0131n Pfizer ve BioNTech\u2019e dava a\u00e7aca\u011f\u0131 duyuruldu. Moderna\u2019n\u0131n yapt\u0131\u011f\u0131 a\u00e7\u0131klamada, \u201c\u0130ki \u015firket \u00e7\u0131\u011f\u0131r a\u00e7an teknolojiyi \u00e7ald\u0131\u201d denildi. ABD merkezli \u015firket mRNA teknolojisinin patentlerinin kendilerinde oldu\u011funu duyururken yasal yollara ba\u015fvurulaca\u011f\u0131n\u0131 da kaydetti.<\/p>\n
\u201cAMACIMIZ P\u0130YASADAN \u00c7EK\u0130LMES\u0130 DE\u011e\u0130L\u201d<\/strong><\/p>\n T\u00fcrkiye\u2019de de kullan\u0131lan ve Comirnaty ismiyle isteyen ve uygun ki\u015filere yap\u0131lan a\u015f\u0131n\u0131n ak\u0131beti ile ilgili de Moderna\u2019dan bir a\u00e7\u0131klama geldi. 6 milyondan fazla insan\u0131n \u00f6l\u00fcm\u00fcne sebep olan Covid-19 salg\u0131n\u0131na kar\u015f\u0131 a\u015f\u0131laman\u0131n devam etmesi gerekti\u011fini duyuran\u00a0 ABD\u2019li \u015firket, \u201cAmac\u0131m\u0131z Pfizer\/BioNTech a\u015f\u0131s\u0131n\u0131n pazardan \u00e7ekilmesini ya da kullan\u0131lmamas\u0131 de\u011fil\u201d diyerek bu a\u015f\u0131lar\u0131n kullan\u0131m\u0131na devam edilebilece\u011finin sinyalini verdi.<\/p>\n Moderna 8 Mart\u2019tan sonraki b\u00fct\u00fcn zararlar\u0131n kar\u015f\u0131lanmas\u0131 i\u00e7in harekete ge\u00e7tiklerini duyururken \u015firketin CEO\u2019su Steohane Bancel de, \u201cBiz yaratmak i\u00e7in milyarlarca dolar yat\u0131r\u0131m yapt\u0131\u011f\u0131m\u0131z ve geli\u015ftirdi\u011fimiz mRNA teknolojisini korumak i\u00e7in bu davalar\u0131 a\u00e7\u0131yoruz\u201d ifadesini kulland\u0131. Moderna ayr\u0131ca Pfizer ve BioNTech\u2019in az geli\u015fmi\u015f 92 \u00fclkeye yapt\u0131\u011f\u0131 sat\u0131\u015ftan elde edilen gelirlere y\u00f6nelik de dava a\u00e7\u0131lmayaca\u011f\u0131n\u0131n alt\u0131n\u0131 \u00e7izdi.<\/p>\n Financial Times, \u00f6zel haberinde Pfizer ve BioNTech\u2019ten yetkililerle ileti\u015fime ge\u00e7tiklerini a\u00e7\u0131klarken bu \u015firketlerden Moderna\u2019n\u0131n hamlesi ve davas\u0131 ile ilgili bir yan\u0131t gelmedi\u011fi belirtildi.<\/p>\n","protected":false},"excerpt":{"rendered":" T\u00fcrkiye’de de kullan\u0131lan mRNA bazl\u0131 Covid-19 a\u015f\u0131s\u0131n\u0131 \u00fcreten Pfizer ile BioNTech’e \u015fok su\u00e7lama ABD merkezli ila\u00e7 \u015firketi Moderna’dan geldi …<\/p>\n","protected":false},"author":1,"featured_media":31566,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30],"tags":[2043,6634,1940,6635,217],"class_list":["post-31565","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik","tag-biontech","tag-moderna","tag-mrna","tag-pfizer","tag-sirket"],"_links":{"self":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/31565","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=31565"}],"version-history":[{"count":1,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/31565\/revisions"}],"predecessor-version":[{"id":31567,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/posts\/31565\/revisions\/31567"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=\/wp\/v2\/media\/31566"}],"wp:attachment":[{"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=31565"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=31565"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/haberulus.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=31565"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}